These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2005-001481-14 LOCAL-TAX Trial: Local intracoronary administration of Paclitaxel after stent implantation for prevention of restenosis in comparison with stent implantation alone and with implantation of a Paclitaxe... not-yet-due
Listed as ongoing, but also has a completion date 2005-003305-90 A Randomized Phase II Study to Determine the Most Promising Postgrafting Immunosuppression for Prevention of Acute GVHD after Unrelated Donor G-CSF mobilized Peripheral Blood Mononuclear Cell (G-PBMC)... 2014-12-31 bad-data
Not reported Terminated 2005-004540-31 Monozentrische, randomisierte, placebo-kontrollierte Studie zur Evaluation der Nephroprotektion durch Theophyllin unter Cisplatin-haltiger Chemotherapie 2009-12-15 due-trials
Exempt 2005-005678-61 Entwicklung einer Untersuchungsmethode zur Bestimmung des NO-Transferfaktors der Lunge Evaluierung der Methode und Normwerterhebung an gesunden Probanden (Development of a new method for steady-state ... not-yet-due
Not reported 2006-003816-23 Multicenter phase II study with pemetrexed in patients with pre-treated metastatic soft tissue sarcomas 2009-12-15 due-trials
Not reported Terminated 2007-000353-65 Weight gain, eating patterns, and development of body composition during initiation of basal insulin therapy: a comparison of insulin detemir and insulin glargine 2012-10-18 due-trials
Not reported Terminated 2007-000775-42 Effects of Rimonabant on Liver Fat, Visceral Adipose Tissue Mass and early Markers of CardioDiabetes in obese Subjects with the Metabolic Syndrome – a randomized, double-blind clinical trial 2008-12-15 due-trials
Ongoing 2007-001478-10 CWS-2007-HR: A randomised phase-III trial of the Cooperative Weichteilsarkom Studiengruppe for localised high-risk Rhabdomyosarcoma and localised Rhabdomyosarcoma-like Soft Tissue Sarcoma in children,... not-yet-due
Ongoing 2007-003858-29 Prospektive multizentrische Phase-III-Studie zur ambulanten Therapie mit Capecitabin versus Cisplatin plus Capecitabin beim fortgeschrittenen Adenokarzinom der Gallenblase und Gallenwege („CISCA-Studi... not-yet-due
Not reported 2007-003986-42 Prospective, randomised, placebo controlled, double blind monocenter trial for the prophylactic treatment of diarrhoea with rifaximin for travellers to South- and Southeast-Asia 2012-09-21 due-trials
Not reported 2007-005063-96 Prospective trial of intravenous levetiracetam in patients with primary brain tumors and at least one symptomatic seizure who undergo biopsy or cytoreductive surgery. 2009-08-19 due-trials
Completed, but no date Terminated 2007-006016-33 Multicenter Phase II study of haploidentical hematopoietic cell transplantation with CD3/CD19 depleted grafts after a reduced intensity conditioning regimen for adult patients with acute leukemia bad-data
Listed as ongoing, but also has a completion date 2009-012203-26 Efficacy and safety of inhaled Budesonide in Very Preterm Infants at Risk for Bronchopulmonary Dysplasia. 2016-07-31 bad-data
Ongoing 2009-015936-14 PHASE II FEASIBILITY STUDY USING CH14.18/CHO ANTIBODY AND SUBCUTANEOUS INTERLEUKIN 2 AFTER HAPLOIDENTICAL STEM CELL TRANSPLANTATION IN CHILDREN WITH RELAPSED NEUROBLASTOMA not-yet-due
Not reported 2010-019033-98 A phase II study to evaluate safety and efficacy of combined treatment with ipilimumab and intratumoral interleukin-2 in pretreated patients with stage IV melanoma 2015-06-23 due-trials
Ongoing 2010-021576-28 Effects of transfusion thresholds on neurocognitive outcome of extremely low birth weight infants (ETTNO) a blinded randomized controlled multicenter trial not-yet-due
Not reported Terminated 2010-022103-21 Neoadjuvant treatment of locoregional metastases in malignant melanoma (AJCC stage IIIB/C) with Multiferon: a phase IIa DeCOG trial 2013-03-31 due-trials
Ongoing 2010-024152-29 Canakinumab for Behçet`s Disease Resistant to Standard Treatment not-yet-due
Ongoing 2011-000659-18 Treatment of therapy resistant Alopecia areata with fumaric acid esters (Fumaderm® and Fumaderm initial®) – an open, single center, non-randomized, pilot study with 40 patients not-yet-due
Not reported 2011-002192-41 Multicenter phase II study of peritransplantation immunosuppression using ATG, rituximab, sirolimus and mycophenolate mofetil in patient receiving mismatched hematopoietic cell transplantation after r... 2016-08-17 due-trials
Ongoing 2011-002434-40 Highdose Chemotherapy and transplantation of 34+ selected stem cell for progressive systemic sclerosis Modification according to manifestation not-yet-due
Completed, but no date Terminated 2011-002920-41 Open-label Trial of Stelara® (Ustekinumab) In Patients with Pyoderma gangrenosum – an open, non-placebo controlled pilot study with 10 patients. bad-data
Not reported Terminated 2011-004405-25 Study for prevention of peritoneal carcinomatosis in patients with stomach cancer 2015-06-09 due-trials
Ongoing 2012-005617-39 Pharmacokinetics of Tigecycline in Patients Receiving Continuous Renal Replacement Therapy not-yet-due
Ongoing 2013-001546-34 Neoadjuvant treatment with the combination of vemurafenib and cobimetinib (GDC-0973) in limited metastasis of malignant melanoma (AJCC stage IIIC/IV) and integrated biomarker study: a single armed ph... not-yet-due
Completed, report not yet due 2013-003306-45 An open-label, uncontrolled, single arm phase II trial of BKM120 (Buparlisib) in patients with metastatic melanoma with brain metastases not eligible for surgery or radiosurgery 2018-07-31 not-yet-due
Not reported 2013-003678-29 Phase II multicenter, open‐label, single arm clinical Study of Pomalidomide and dexamethasonE in RelapSed myeloma Plus rEsponse adapted Cyclophosphamide as a Tailored InnoVativE strategy 2017-08-01 due-trials
Exempt 2014-003561-15 Safety and Tolerance of Immunomodulating Therapy with Donor-specific Mesenchymal Stem Cells in Pediatric Living-Donor Liver Transplantation not-yet-due
Ongoing 2014-003581-25 Anti-inflammatory pulmonal therapy of CF-patients with Amitriptyline and Placebo - Randomised, double-blind, placebo-controlled cohort trial not-yet-due
Ongoing 2014-005004-21 THOR - Tübingen Choroideremia gene therapy trial open label Phase 2 clinical trial using an adeno-associated viral vector (AAV2) encoding Rab-escort protein 1 (REP1) not-yet-due
Ongoing 2014-005109-19 Apixaban for treatment of embolic stroke of undetermined source not-yet-due
Ongoing 2015-000125-36 Daptomycin concentration in drainage fluid and blood samples of ICU patients not-yet-due
Not reported 2015-000978-35 Statin Treatment of Oxysterol Pathology in SPG5: a Randomized Controlled Trial -Proof of Principle 2016-03-01 due-trials
Ongoing 2015-002288-41 Open-label pilot Phase I / II study on hyperthermic intraperitoneal chemotherapy ( HIPEC ) after macroscopically complete resection ( R0 / R1 ) of adenocarcinomas of the pancreas ( PanHIPEC ) not-yet-due
Completed, but no date Terminated 2015-003171-29 The correlation between vancomycin AUC and trough levels during intermittent dosing of vancomycin and plateau levels during continuous infusion - Pharmacokinetic evaluation of Vancomycin and the influ... bad-data
Ongoing 2015-005281-29 Prospective phase I/II study: Patient-individualized peptide vaccination based on whole exome sequencing with adjuvant GM-CSF in children with relapsed acute lymphoblastic leukemia not-yet-due
Ongoing 2015-005740-34 Effectiveness of Dapagliflozin + Saxagliptin to revert from a standard basalbolus insulin treatment (BBIT) regimen to a basal supported oral therapy (BOT) in patients with Type 2 Diabetes – a randomis... not-yet-due
Ongoing 2015-005817-61 iVAC-CLL01: Patient-individualized peptide vaccination after first line therapy of CLL not-yet-due
Other 2016-000222-19 Effect of ALlopurinol in addition to hypothermia for hypoxic-ischemic Brain Injury on Neurocognitive Outcome – a blinded randomized placebo-controlled parallel group multicenter trial for superiority ... not-yet-due
Ongoing 2016-000432-17 A Clinical Phase II, multicenter, Open-label study evaluating iNduction, consolidation and maintenance treatment with Isatuximab (SAR650984), Carfilzomib, LEnalidomide and Dexamethasone (I-KRd) in Pri... not-yet-due
Ongoing 2016-000433-51 DAratumumab iN combination with BorTEzomib and Dexamethasone in subjects with relapsed or relapsed and refractory Multiple Myeloma and severe renal impairment including subjects undergoing hemodialysi... not-yet-due
Ongoing 2016-003223-30 Prophylactic treatment of hemiplegic migraine with Lamotrigine not-yet-due
Ongoing 2016-003477-18 A double-blind randomized study to determine the effect of empagliflozin versus placebo on brain insulin sensitivity in patients with prediabetes not-yet-due
Ongoing 2016-004505-13 Tocilizumab for the Treatment of Familial Mediterranean Fever – A randomized, doubleblind, phase II proof of concept study-TOFFIFE not-yet-due
Ongoing 2016-004614-10 An open label phase II study to evaluate safety and efficacy of combined treatment with ipilimumab and nivolumab in patients with four and more symptomatic brain metastases of melanoma not-yet-due
Ongoing 2017-001355-31 Penumbral Rescue by Normobaric O=O Administration in Patients with Ischemic Stroke and Target Mismatch ProFile: not-yet-due
Ongoing 2017-002723-16 Evaluation of the potential anti-malarial effect of ivermectin: a controlled human malaria infection trial not-yet-due
Exempt 2017-003387-12 Dopamine action on metabolism depending on genetic heterogeneity – a randomized, placebo-controlled double blind study not-yet-due
Ongoing 2018-000453-41 Effects of closed-loop automatic control of the inspiratory fraction of oxygen (FiO2-C) on outcome of extremely preterm infants – a randomized controlled parallel group multicenter trial for safety an... not-yet-due
Ongoing 2018-003557-21 Effect of insulin glargine and lixisenatide versus insulin glargine on brain insulin sensitivity in patients with type 2 diabetes not-yet-due